Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
Author(s) -
Amin Faisal Ellakwa,
Hatem M. Marey
Publication year - 2011
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s21453
Subject(s) - medicine , trabeculectomy , bevacizumab , ophthalmology , intraocular pressure , glaucoma , mitomycin c , neovascular glaucoma , visual acuity , glaucoma surgery , surgery , diabetic retinopathy , chemotherapy , diabetes mellitus , endocrinology
To demonstrate the role of intravitreal bevacizumab in regression of iris neovascularization, and intraocular pressure (IOP) control in neovascular glaucoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom